RBC Europe’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	$1K	Hold	60	–	–	﹤0.01%	597
2022 Q1	$2K	Buy	+60	New	+$2K	﹤0.01%	595